New brain tumor scan could sharpen treatment decisions
NCT ID NCT06667726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial at Mayo Clinic is testing whether adding an amino acid PET/CT scan (using a radioactive tracer called FDOPA) to standard imaging can improve clinical management for people with brain tumors. The study will enroll 47 adults with brain tumors to see if the extra scan changes treatment plans in over half of cases. Researchers will also track side effects and whether the scan finds tumors outside standard MRI areas.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fluorodopa F 18 (18F-DOPA)
- What this could lead to
- If successful, this imaging technique could help doctors better plan treatment for brain tumors, such as surgery or radiation, and more accurately distinguish tumor growth from treatment side effects.
- What could go wrong
- This is a small, early-phase trial with only 47 participants, so results may not apply to everyone. The scan involves a radioactive tracer, though doses are very low.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Could a cancer drug shrink recurrent brain tumors?
- New PET tracer could spot cancers that standard scans overlook